Evidence-Based Nursing to Reduce Adverse Events Regarding Ventilator Associated Pneumonia, Pressure Injuries and Central Line Bloodstream Infection in Intensive Care Unit in Bangladesh

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHiroshima University

About this trial

Quality of care is crucial for preventing adverse events such as infection in the intensive care units (ICUs). The most common ICU-acquired infections include pneumonia such as Ventilator Associated Pneumonia (VAP), Pressure Ulcer (PU), Medical Device Related Pressure Ulcer (MDRPU), and Central Line-Associated Bloodstream Infection (CLABSI). VAP, PU, and MDRPU are significant indicators of the quality of care, while CLABSI is a critical marker of healthcare quality in ICUs, as it is largely preventable through strict adherence to infection control protocols.

VAP is a lung infection that occurs in patients receiving mechanical ventilation for more than 48 hours. A PU is defined as localized damage to the skin or underlying tissue caused solely by pressure, while MDRPUs may also result from friction or pressure from medical devices or other objects. CLABSI is a severe infection caused by improperly inserted or maintained central venous catheters, which underscores the need for stringent catheter management protocols.

Eligibility criteria

Qualifiers

who is a registered nurse in Bangladesh.

who agrees to participate in this study and the EBP training.

who will stay at the ICU for 6 months. Patient

Irrespective of age and sex, participants must be at least 18 years old

Disqualifiers

Who will not directly involve patient care in ICU. Patient

No exclusion criteria

Trial design

Treatments tested in this trial

  • Education with EBP
  • This is a pre- and post- quasi-experimental study.

Treatment groups

272 Participants
are divided into 1 treatment group

Sponsors and collaborators